-
Stocks slide as US inflation surges, US and Iran trade strikes
-
Surging US consumer inflation hits three-year high in key challenge for Trump
-
Vaughan backs Stokes to stay on as England captain
-
Bill Gates arrives for questioning in US Congress over Epstein ties
-
Amnesty accuses Israel of 'ethnic cleansing' of West Bank Bedouins
-
German consortium hopes to build new fighter jet after FCAS collapse
-
O'Callaghan and Short clock history-making times at Australian trials
-
Trump says Iran 'taken too long to negotiate,' will have to 'pay the price'
-
Pakistan launches deadly strikes on Afghanistan
-
Israel's Netanyahu to seek re-election despite Trump doubts, war strains
-
Stocks drop ahead of key US inflation data
-
6-7, Bad Bunny, AI: Pope targets the young
-
FIFA boss Infantino faces questions on eve of World Cup
-
Iran attacks US bases in Jordan and Bahrain
-
Tech leads Asia losses as rollercoaster week rumbles on
-
Belfast stabbing suspect due in court after night of violence
-
Saudi's new national carrier gets off ground despite war, delays
-
Eddie Jones eyes Mourinho-like laundry stunt to escape ban
-
Bollywood's Imtiaz Ali bets on Gen Z thirst for love
-
Messi plushies see roaring trade as China firms get World Cup boost
-
Messi sparkles on return as Somali referee says World Cup dream over
-
Iran, US trade blows as Middle East peace deal draws no nearer
-
Salt: integral ingredient of sumo stars' art
-
Staal shines as Carolina beat Vegas 5-3 to level Stanley Cup Final
-
Messi scores on injury return as Argentina beat Iceland in World Cup warm-up
-
Art, maths and killing: Ukraine drone chief's formula to stop Russia
-
Tech leads Asia losses, oil rises as rollercoaster week rumbles on
-
Messi set to return as Somali referee says World Cup dream over
-
Former Wallabies skipper Wright signs for Welsh club Ospreys
-
Pope to bless Barcelona's Sagrada Familia, world's tallest church
-
Emotional World Cup return to Mexico for South Africa coach Broos
-
Bill Gates faces questioning in US Congress over Epstein ties
-
'The Donald of Dubai': property tycoon seeks to become data king
-
PGA Tour to co-sanction Australian Open in global push
-
Elon Musk, after DOGE and politics, bets on SpaceX IPO
-
Saudis in World Cup spotlight after $2bn spending spree
-
Mexico doubles down on security before 2026 World Cup
-
US must not be 'too honest' at World Cup, says Roldan
-
Italian astronaut to pilot Artemis III mission
-
North Korea says Xi's visit produced 'far-reaching blueprint' for ties
-
Benfica say farewell to Mourinho as Real Madrid return nears
-
Protesters torch buildings and vehicles, block roads over Belfast stabbing
-
US strikes Iran after Apache helicopter downing
-
Threats to US lawmakers spiked after Meta eased moderation: watchdog
-
Nick Reiner seeks trust fund money for parent murder defense
-
Spain, France qualify for 2027 Women's World Cup as England wait
-
Protesters torch building and vehicles, block roads over Belfast stabbing
-
A woman in charge of the UN? Candidates feel it's about time
-
US tech shares resume sell-off while oil prices retreat
-
Protesters block road to Mexican World Cup stadium
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
J.AbuShaban--SF-PST